Turner JR - Search Results

1

Distinct temporal-spatial roles for rho kinase and myosin light chain kinase in epithelial purse-string wound closure.

Russo JM, Florian P, Shen L, Graham WV, Tretiakova MS, Gitter AH, Mrsny RJ, Turner JR. Russo JM, et al. Among authors: turner jr. Gastroenterology. 2005 Apr;128(4):987-1001. doi: 10.1053/j.gastro.2005.01.004. Gastroenterology. 2005. PMID: 15825080 Free PMC article.

2

A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.

Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, Tom J, Mrsny RJ, Turner JR. Zolotarevsky Y, et al. Among authors: turner jr. Gastroenterology. 2002 Jul;123(1):163-72. doi: 10.1053/gast.2002.34235. Gastroenterology. 2002. PMID: 12105845

3

High-molecular-weight polyethylene glycol prevents lethal sepsis due to intestinal Pseudomonas aeruginosa.

Wu L, Zaborina O, Zaborin A, Chang EB, Musch M, Holbrook C, Shapiro J, Turner JR, Wu G, Lee KY, Alverdy JC. Wu L, et al. Among authors: turner jr. Gastroenterology. 2004 Feb;126(2):488-98. doi: 10.1053/j.gastro.2003.11.011. Gastroenterology. 2004. PMID: 14762786

4

A porous defense: the leaky epithelial barrier in intestinal disease.

Clayburgh DR, Shen L, Turner JR. Clayburgh DR, et al. Among authors: turner jr. Lab Invest. 2004 Mar;84(3):282-91. doi: 10.1038/labinvest.3700050. Lab Invest. 2004. PMID: 14767487 Free article. Review.

5

Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coli.

Tomson FL, Koutsouris A, Viswanathan VK, Turner JR, Savkovic SD, Hecht G. Tomson FL, et al. Among authors: turner jr. Gastroenterology. 2004 Sep;127(3):859-69. doi: 10.1053/j.gastro.2004.06.014. Gastroenterology. 2004. PMID: 15362041

6

A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability.

Clayburgh DR, Rosen S, Witkowski ED, Wang F, Blair S, Dudek S, Garcia JG, Alverdy JC, Turner JR. Clayburgh DR, et al. Among authors: turner jr. J Biol Chem. 2004 Dec 31;279(53):55506-13. doi: 10.1074/jbc.M408822200. Epub 2004 Oct 26. J Biol Chem. 2004. PMID: 15507455 Free PMC article.

7

Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease.

Siccardi D, Turner JR, Mrsny RJ. Siccardi D, et al. Among authors: turner jr. Adv Drug Deliv Rev. 2005 Jan 6;57(2):219-35. doi: 10.1016/j.addr.2004.08.005. Adv Drug Deliv Rev. 2005. PMID: 15555739 Review.

8

Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.

Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Wang F, et al. Among authors: turner jr. Am J Pathol. 2005 Feb;166(2):409-19. doi: 10.1016/s0002-9440(10)62264-x. Am J Pathol. 2005. PMID: 15681825 Free PMC article.

9

Serotonin inhibits Na+/H+ exchange activity via 5-HT4 receptors and activation of PKC alpha in human intestinal epithelial cells.

Gill RK, Saksena S, Tyagi S, Alrefai WA, Malakooti J, Sarwar Z, Turner JR, Ramaswamy K, Dudeja PK. Gill RK, et al. Among authors: turner jr. Gastroenterology. 2005 Apr;128(4):962-74. doi: 10.1053/j.gastro.2005.02.011. Gastroenterology. 2005. PMID: 15825078

10

A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase.

Owens SE, Graham WV, Siccardi D, Turner JR, Mrsny RJ. Owens SE, et al. Among authors: turner jr. Pharm Res. 2005 May;22(5):703-9. doi: 10.1007/s11095-005-2584-9. Epub 2005 May 17. Pharm Res. 2005. PMID: 15906163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

896 results

Search Page

Filters